<?xml version="1.0" encoding="UTF-8"?>
<p>Four European governments (of Italy, Germany, France and The Netherlands) for their citizens has signed contract with British Pharmaceuthical company “AstraZeneca” to supply the region with its potential vaccine against the coronavirus - the British drugmaker’s latest deal to pledge its drug to help combat the pandemic. The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, which will be produced until the end of the year 2020, as announced Minister of Haelth of Italy, Roberto Speranza. The deal is the first contract signed by Europe’s Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible (
 <xref rid="ref2" ref-type="bibr">2</xref>).
</p>
